Edwards Lifesciences EW Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.94B-3.9% | $3.06B+166% | $1.15B+48.6% | $772.6M-10.9% | ||
| $659.6M+8.3% | $609.1M-21.0% | $771.5M+20.0% | $643M+10.4% | ||
| $1.13B+3.6% | $1.09B+20.3% | $903.5M+3.2% | $875.5M+20.5% | ||
| $6.74B+7.2% | $6.29B+55.7% | $4.04B+30.4% | $3.1B-2.7% | ||
| $1.81B+7.5% | $1.69B+6.0% | $1.59B-2.6% | $1.63B+5.6% | ||
| $1.77B-0.5% | $1.78B+55.2% | $1.15B+7.5% | $1.06B-8.8% | ||
| $13.7B+4.9% | $13.06B+39.4% | $9.36B+12.9% | $8.29B-2.5% | ||
| $227.5M+15.2% | $197.4M+5.8% | $186.6M-7.6% | $201.9M-1.3% | ||
| $1.81B+20.5% | $1.51B+25.9% | $1.2B+16.9% | $1.02B-1.0% | ||
| $598.3M+0.1% | $597.7M+0.1% | $597M+0.1% | $596.3M+0.1% | ||
| $35.1M-98.8% | $2.99B+13.2% | $2.64B+6.4% | $2.49B-6.8% | ||
| $14.24B+8.2% | $13.17B+46.4% | $8.99B+18.5% | $7.59B+25.1% | ||
| $10.34B+3.4% | $10B+50.4% | $6.65B+14.5% | $5.81B-0.5% | ||
| $13.7B+4.9% | $13.06B+39.4% | $9.36B+12.9% | $8.29B-2.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Edwards Lifesciences's total assets?
- Edwards Lifesciences (EW) holds $13.3B in total assets, up 2.3% year over year.
- How much debt does Edwards Lifesciences have?
- Edwards Lifesciences carries $702.9M in total debt against $10.3B of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Edwards Lifesciences have?
- Edwards Lifesciences holds $2.4B in cash and equivalents.
- Can Edwards Lifesciences cover its short-term obligations?
- Its current ratio is 4.42 — current assets exceed current liabilities.
- Where does Edwards Lifesciences's balance sheet data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
